Literature DB >> 12100519

Differential expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in ulcerative colitis and Crohn's disease.

Seiji Arihiro1, Haruo Ohtani, Manabu Suzuki, Masahiro Murata, Chieko Ejima, Motoji Oki, Yoshitaka Kinouchi, Kouhei Fukushima, Iwao Sasaki, Shiro Nakamura, Takayuki Matsumoto, Akira Torii, Gotaro Toda, Hiroshi Nagura.   

Abstract

Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) is selectively expressed in the endothelial cells of intestinal mucosa and gut-associated lymphoid tissue (GALT). Engagement of MAdCAM-1 to its ligand, integrin alpha4beta7, on lymphocytes is associated with the homing of gut-associated lymphocytes to normal gastrointestinal tract and inflammation sites. The present study was designed to elucidate differences between Crohn's disease (CrD) and ulcerative colitis (UC) from the expression patterns of MAdCAM-1. Samples were taken from 40 patients with CrD and 24 patients with UC at surgical resection. Using frozen sections, immunohistochemistry was performed for MAdCAM-1, E-selectin and CD34. MAdCAM-1+ venules were abundant in inflamed mucosa in both UC and CrD. In contrast, clear differences were noted between UC and CrD in the inflammatory area in the ulcer base, that is, MAdCAM-1+ venules were more abundant in CrD than in UC (P < 0.001), while E-selectin was expressed equally in these venules in both diseases. Furthermore, CrD was characterized by the occurrence of MAdCAM-1+ venules in deeper layers of the intestinal tissue, mainly in lymphoid aggregates. Our data indicated more extensive expression of MAdCAM-1 in CrD, which could contribute not only to mucosal inflammation, but also to transmural inflammation in CrD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100519     DOI: 10.1046/j.1440-1827.2002.01365.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  33 in total

Review 1.  Two distinct lymphocyte homing systems involved in the pathogenesis of chronic inflammatory gastrointestinal diseases.

Authors:  Motohiro Kobayashi; Hitomi Hoshino; Kenichi Suzawa; Yasuhiro Sakai; Jun Nakayama; Minoru Fukuda
Journal:  Semin Immunopathol       Date:  2012-05-10       Impact factor: 9.623

Review 2.  Dendritic cells in intestinal homeostasis and disease.

Authors:  Maria Rescigno; Antonio Di Sabatino
Journal:  J Clin Invest       Date:  2009-09-01       Impact factor: 14.808

Review 3.  Vedolizumab: first global approval.

Authors:  Raewyn M Poole
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

Review 4.  Meta-analysis of the effectiveness and safety of vedolizumab for ulcerative colitis.

Authors:  Yu Jin; Yan Lin; Lian-Jie Lin; Chang-Qing Zheng
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

Review 5.  Biological therapy for ulcerative colitis: an update.

Authors:  Geom Seog Seo; Soo-Cheon Chae
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

6.  Increased Cell Adhesion Molecules, PECAM-1, ICAM-3, or VCAM-1, Predict Increased Risk for Flare in Patients With Quiescent Inflammatory Bowel Disease.

Authors:  Phillip Gu; Arianne Theiss; Jie Han; Linda A Feagins
Journal:  J Clin Gastroenterol       Date:  2017-07       Impact factor: 3.062

7.  Skin- and gut-homing molecules on human circulating γδ T cells and their dysregulation in inflammatory bowel disease.

Authors:  E R Mann; N E McCarthy; S T C Peake; A N Milestone; H O Al-Hassi; D Bernardo; C T Tee; J Landy; M C Pitcher; S A Cochrane; A L Hart; A J Stagg; S C Knight
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

8.  Expression of mucosal addressin cell adhesion molecule 1 on vascular endothelium of gastric mucosa in patients with nodular gastritis.

Authors:  Hiroshi Ohara; Hajime Isomoto; Chun-Yang Wen; Chieko Ejima; Masahiro Murata; Masanobu Miyazaki; Fuminao Takeshima; Yohei Mizuta; Ikuo Murata; Takehiko Koji; Hiroshi Nagura; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

Review 9.  What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails?

Authors:  Ian C Lawrance
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

10.  Indium-labelled human gut-derived T cells from healthy subjects with strong in vitro adhesion to MAdCAM-1 show no detectable homing to the gut in vivo.

Authors:  J Kelsen; J Agnholt; L Falborg; J T Nielsen; J L Rømer; H J Hoffmann; J F Dahlerup
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.